Irkutsk
Ulan-Ude

Blagoveshchensk
Chita
Yakutsk

Birobidzhan
Vladivostok
Khabarovsk

Magadan
Yuzhno-Sakhalinsk

Anadyr
Petropavlovsk-
Kamchatsky
Moscow

This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.

Russian hospitals received the first batch of the drug from COVID-19

Russian hospitals received the first batch of the drug from COVID-19
Photo: pixabay.com

The first batch of Avifavir, intended for the treatment of coronavirus, was delivered to Russian hospitals. So far he was brought to the Moscow, Leningrad, Novgorod, Kirov and Nizhny Novgorod regions, Yekaterinburg and the Republic of Tatarstan.

According to the press service of the Russian Direct Investment Fund, in June, 60 thousand courses of the drug will be delivered to hospitals, if necessary, production can be increased to two million courses per year. In addition to the Russian regions, applications for Avifavir came from 10 countries.

The Russian medicine was created on the basis of the Japanese drug Favipiravira, which was originally created for the treatment of influenza. According to the developers, during clinical trials, not everyone, but in most patients taking the medicine, the temperature decreased faster, and the coronavirus test became negative after four days of treatment.

September 23: current information on coronavirus in the Far East
Digest of regional events and latest statistics